News | April 28, 2026
AKUMS launches Aztreonam-Avibactam injection to combat multidrug-resistant infections
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
Subscribe To Our Newsletter & Stay Updated
